EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical spectrum and long-term outcomes of antibody-negative severe autoimmune encephalitis: a retrospective study

Fangfang Li, Yu He, Xiaoqian Chen, Ali Yang, Jiewen Zhang, Weizhou Zang

Frontiers in Immunology · 15.05.2025 · 16

DOI: 10.3389/fimmu.2025.1591771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 15.05.2025. Verfasst von Fangfang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Encephalitis, Autoantibodies, Hashimoto Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aims of the study were to characterize the clinical manifestations and outcomes of patients with antibody-negative severe autoimmune encephalitis (AE).

Methods

This retrospective, monocentric study recruited patients from the Neurology Department of Henan Provincial People’s Hospital between April 2017 and December 2023. All patients underwent neural antibody testing in both blood and cerebrospinal fluid (CSF) and met the diagnostic criteria for autoantibody-negative but probable severe AE, with available 1-year follow-up data.

Results

In total, 124 patients with autoantibody-negative severe AE were analyzed. Among them, 27.4% achieved good functional outcomes at discharge. Older age (OR 1.034, 95% confidence interval [CI] 1.010-1.058, p = 0.004) and the presence of dyskinesia/dystonia (OR 8.463, 95% CI 3.282-21.820, p < 0.001) were predictive of poor short-term outcomes. At the 1-year follow-up, 54.8% experienced favorable long-term outcomes. Independent predictors of unfavorable long-term outcomes included older age (OR 1.076, 95% CI 1.018-1.136, p = 0.009), longer hospital stays (OR 1.264, 95% CI 1.105-1.446, p = 0.001), the presence of refractory status epilepticus (OR 14.765, 95% CI 1.759-123.935, p = 0.013) and higher CASE scores at discharge (OR 2.079, 95% CI 1.450-2.980, p < 0.001). Additionally, 30.6% of patients had relapsed, with refractory status epilepticus being an independent risk factor for relapse.

Conclusion

Although patients with antibody-negative severe AE experience significant disability in the early stages of their disease, the majority eventually regain independent functioning. Older age at disease onset, longer hospital stays, the presence of refractory status epilepticus and higher CASE scores at discharge may predict a poor long-term prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EncephalitisAutoantibodiesHashimoto DiseaseHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedYoung AdultPrognosisAdolescentFollow-Up StudiesTreatment Outcome

Stichwörter der Autor:innen

antibody-negativeautoimmune encephalitisclinical characteristicsprognosissevere

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department of Neurology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
  • Department of Neurology, Henan University People's Hospital, Zhengzhou, China.
  • The Second Affiliated Hospital of Luohe Medical College, Luohe, Henan, China.

Zitieren

APA

Li, F., He, Y., Chen, X., Yang, A., Zhang, J., & Zang, W. (2025). Clinical spectrum and long-term outcomes of antibody-negative severe autoimmune encephalitis: a retrospective study. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1591771

Vancouver

Li F, He Y, Chen X, Yang A, Zhang J, Zang W. Clinical spectrum and long-term outcomes of antibody-negative severe autoimmune encephalitis: a retrospective study. Frontiers in Immunology. 2025;16. doi:10.3389/fimmu.2025.1591771

BibTeX
@article{Li2025,
  author = {Li, Fangfang and He, Yu and Chen, Xiaoqian and Yang, Ali and Zhang, Jiewen and Zang, Weizhou},
  title = {Clinical spectrum and long-term outcomes of antibody-negative severe autoimmune encephalitis: a retrospective study},
  journal = {Frontiers in Immunology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fimmu.2025.1591771}
}
Kostenlos starten →